BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Previous Merck & Co., Inc. (MRK) and Bayer Pharmaceuticals Corporation (CT) Executive Accepts Full Time Role and Company Adds More Experience to Fuse Science Management Team


2/16/2012 6:30:26 AM

MIAMI LAKES, Fla., Feb. 15, 2012 /PRNewswire/ -- Fuse Science Inc. (OTCQB: DROP) (www.fusescience.com), announced today that current advisory board member, Jeanne Hebert, will be accepting a full time role as Vice President of Marketing and Clinical Research, effective immediately. The Company also announced it has added Julie Zastrow to the management team to lead our grass roots marketing, athlete management and social media efforts.

(Logo: http://photos.prnewswire.com/prnh/20110615/CL20255LOGO)

Hebert brings more than 20 years sales, marketing and research experience in the pharmaceutical and medical device industries, having worked for leading global manufacturers Bristol-Myers Squibb, Bayer Pharmaceutical, Merck & Co. and Integral Orthopedics Inc. During her career, she has provided direction on science-based content to strategic objectives for big Pharma and was a member of the Scientific Advisory Board at Merck. Hebert will be advancing product innovation through development and commercialization phases, including work with suppliers on product design and advanced medical prototyping. In her previous executive roles she has led aggressive corporate intellectual property protection efforts, better designs and web protection strategies to strengthen the company's defenses against competition. Jeanne has designed and initiated internal and external clinical studies and provided oversight on testing of new products leading to favorable outcomes and the launch of several new products.

Over the past 18 years Julie Zastrow has held progressive marketing roles building brands. Julie was formerly Vice President of Marketing and Merchandising for TapouT Inc., the number one MMA brand within the UFC. Prior to that, Julie was head of merchandising for Champs Sports and managed athlete integration into the brand.

"We are very pleased to have Jeanne & Julie join our team," said Rubin Hanan, President and COO. "We are aggressively driving our product commercialization efforts, continued research and athlete strategy for the Powered By Fuse brand. The full time commitment of Ms. Herbert and Ms. Zastrow to our business brings immediate positive impact and advancement to this strategy."

Fuse Science recently launched its EnerJel brand with strong demand and Ms. Hebert and Ms. Zastrow will play a key role in the continued commercialization of the Powered by Fuse brand in all forms as the Company expands its distribution and licensing footprint in 2012.

About Fuse Science Inc.

Fuse Science Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida. Fuse Science is the developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company has successfully developed and maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com or by calling 305-503-FUSE (3873).

Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.

SOURCE Fuse Science Inc.



Read at BioSpace.com
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES